Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes.
Khurana I, Kaipananickal H, Maxwell S, Birkelund S, Syreeni A, Forsblom C, Okabe J, Ziemann M, Kaspi A, Rafehi H, Jørgensen A, Al-Hasani K, Thomas MC, Jiang G, Luk AO, Lee HM, Huang Y, Thewjitcharoen Y, Nakasatien S, Himathongkam T, Fogarty C, Njeim R, Eid A, Hansen TW, Tofte N, Ottesen EC, Ma RC, Chan JC, Cooper ME, Rossing P, Groop PH, El-Osta A.
J Clin Invest. 2023 Feb 15;133(4):e160959. doi: 10.1172/JCI160959.
PMID:36633903
Diabetic nephropathy: diagnosis, prevention, and treatment.
Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T.
Diabetes Care. 2021 Jan;44(1):174-180. doi: 10.2337/dc20-0493. Epub 2020 Nov 11.
PMID:33177173
Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study.
Piccoli GB, Clari R, Ghiotto S, Castelluccia N, Colombi N, Mauro G, Tavassoli E, Melluzza C, Cabiddu G, Gernone G, Mongilardi E, Ferraresi M, Rolfo A, Todros T.